Adrenaclick Auto-injector launched for anaphylaxis

Sciele Pharma announced the availability of Adrenaclick (epinephrine injection auto-injector) for the emergency treatment of severe allergic reactions (Type I). These reactions include anaphylaxis to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as anaphylaxis to unknown substances or exercise-induced anaphylaxis.

Adrenaclick is available as a single-dose auto-injector in 0.15mg and 0.3mg dosage strengths as a single unit or a two-pack.

For more information call (800) 849-9707 or visit www.adrenaclick.com.